|
|
³¯Â¥ |
2010-12-02 |
|
|
Á¦¸ñ |
Regulatory Affairs Journal Pharma |
|
|
³»¿ë |
Regulatory Affairs Journal Pharma May 2007 Issue (Vol 18 No 5)
Contents Editorial - Myths about Stem Cell Research
The Failure of Trade Marks to Protect against Parallel Imports Maureen Kenny says that pharma companies may not be able to use trade marks to curtail parallel imports in the EU for much longer
RAJ Briefing - PDUFA-IV Will Focus on Drug Safety Peter Charlish examines the evolution of the drug user fee programme in the US
Europe's Plans to Fine Drug Companies Genevieve Michaux says proposed financial penalties for companies violating EU pharmaceutical rules are too tough
Stem Cell Research in India Geeta Jotwani talks to RAJ about updated guidelines on stem cell research
The Swedish MPA - Driving Regulation through Learning Victoria English describes the work of the Swedish Medical Products Agency
Benefit:Risk Assessments for Veterinary Medicines in the EU Rick Clayton and David Mackay report on key issues in veterinary medicine
°ü·ÃURL : http://www.pjbpubs.com/raj_pharma/index.htm
|
|
|